Niti Goel, MD, FACR is a board-certified physician-scientist who brings to light the clinical and market potential of new molecules and products. She brings nearly 25 years of academic, clinical development, and medical affairs experience in biotech to pharma and contract research organizations.
Areas of expertise:
novel, bespoke, clinical trial design in early to late stage product development
successful global regulatory interactions and approvals
growth and management of successful teams in multiple organizational structures
global health outcomes, clinical operations, patient recruitment, and managed markets
small molecules, biological therapies (including biosimilars), and cellular therapies
autoimmune and autoinflammatory diseases including the rheumatologic, pulmonary, gastrointestinal, and dermatologic therapeutic areas as well as musculoskeletal pain conditions.
Dr. Goel is an adjunct Assistant Professor of Medicine at Duke University School of Medicine in the Division of Rheumatology. Prior to consulting, she was CMO at Kezar Life Sciences; held several roles at IQVIA, the Human Data Science Company, including Vice President, Advisory Services, Strategic Drug Development; and Head, Rheumatology Center of Excellence; and various roles at Array BioPharma, Inc., UCB Pharma, and P&G Pharmaceuticals (Procter & Gamble). Dr. Goel received her Bachelor of Science degree with honors from Pennsylvania State University and graduated summa cum laude with her M.D. degree from Jefferson Medical College, Thomas Jefferson University. She completed her internal medicine and rheumatology training at Duke University Medical Center.
Dr. Goel’s interests include her family as well as music, dance, travel, reading, cooking, and nature.